Chronic insomnia
- PMID: 18519533
- PMCID: PMC2859710
- DOI: 10.1176/appi.ajp.2008.08010129
Chronic insomnia
Abstract
Ms. F, a 42-year-old divorced woman, presents for evaluation of chronic insomnia. She complains of difficulty falling asleep, often 30 minutes or longer, and difficulty maintaining sleep during the night, with frequent awakenings that often last 30 minutes or longer. These symptoms occur nearly every night, with only one or two “good” nights per month. She typically goes to bed around 10:00 p.m. to give herself adequate time for sleep, and she gets out of bed around 7:00 a.m. on work days and as late as 9:00 a.m. on weekends. Her nighttime sleep problems result in daytime irritability and difficulty focusing and organizing her thoughts, which subjectively impair her work as an administrative assistant, although her performance evaluations have been satisfactory. She says that she has “no energy for anything extra,” that her house is a mess, and that she routinely declines invitations to join social and even family activities. Her insomnia began approximately 5 years ago during a period of increased life stress related to a difficult divorce and a job change. At that time she was diagnosed with major depression and was started on a successful trial of escitalopram, which she continues at a dose of 10 mg/day. Her current symptoms are distinct from those that were associated with her episode of major depression. She denies pervasive sadness or loss of interest, but she is very frustrated with her inability to function more effectively, which she attributes to her insomnia. In fact, she believes that her cognitive difficulties and irritability are most noticeable after nights of particularly poor sleep. Her medical history is unremarkable other than a past history of Graves’ disease. She has been treated with levothyroxine for the past 15 years.
How should Ms. F be evaluated? What medical testing, if any, would be appropriate? What factors should be considered in formulating a treatment plan? What treatments would be appropriate?
Figures
Similar articles
-
[Diagnosis and therapy of insomnia].MMW Fortschr Med. 2010 Mar 4;152(9):70-3. MMW Fortschr Med. 2010. PMID: 20384103 German. No abstract available.
-
Insomnia: evidence-based approaches to assessment and management.Clin Med (Lond). 2011 Jun;11(3):278-81. doi: 10.7861/clinmedicine.11-3-278. Clin Med (Lond). 2011. PMID: 21902086 Free PMC article. No abstract available.
-
[Sleep disorders--what can be done when hypnotics no longer help? Overview and case report].Fortschr Neurol Psychiatr. 1995 Sep;63(9):368-72. doi: 10.1055/s-2007-996638. Fortschr Neurol Psychiatr. 1995. PMID: 7590562 Review. German.
-
Managing insomnia.Orthop Nurs. 2006 Sep-Oct;25(5):339-45; quiz 346-7. doi: 10.1097/00006416-200609000-00013. Orthop Nurs. 2006. PMID: 17035922
-
Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.Am J Ther. 2007 May-Jun;14(3):299-305. doi: 10.1097/MJT.0b013e31804c7292. Am J Ther. 2007. PMID: 17515707 Review.
Cited by
-
Knowledge mapping of chronic insomnia: a bibliometric analysis (2000-2023).Sleep Breath. 2024 Aug;28(4):1499-1512. doi: 10.1007/s11325-024-03049-6. Epub 2024 May 10. Sleep Breath. 2024. PMID: 38730203 Review.
-
Randomized, Double-Blind, Placebo-Controlled, Clinical Study of Passiflora incarnata in Participants With Stress and Sleep Problems.Cureus. 2024 Mar 20;16(3):e56530. doi: 10.7759/cureus.56530. eCollection 2024 Mar. Cureus. 2024. PMID: 38646244 Free PMC article.
-
Trends in the multiple prescriptions of hypnotic drugs in a university outpatient in Japan.Neuropsychopharmacol Rep. 2024 Mar;44(1):80-89. doi: 10.1002/npr2.12386. Epub 2023 Nov 9. Neuropsychopharmacol Rep. 2024. PMID: 37946602 Free PMC article.
-
Mind, Body and Machine: Preliminary Study to Explore Predictors of Treatment Response After a Sleep Robot Intervention for Adults with Insomnia.Nat Sci Sleep. 2023 Jul 13;15:567-577. doi: 10.2147/NSS.S408714. eCollection 2023. Nat Sci Sleep. 2023. PMID: 37465662 Free PMC article.
-
Development and validation of the Japanese version of the Hyperarousal Scale.BMC Psychiatry. 2022 Sep 19;22(1):617. doi: 10.1186/s12888-022-04243-0. BMC Psychiatry. 2022. PMID: 36123639 Free PMC article.
References
-
- American Psychiatric Association. Text Revision. 4th ed. Washington, DC: American Psychiatric Association; 2000. Diagnostic and Statistical Manual of Mental Disorders.
-
- American Academy of Sleep Medicine. Diagnostic and Coding Manual. 2nd ed. Westchester, Ill: American Academy of Sleep Medicine; 2005. The International Classification of Sleep Disorders.
-
- Hohagen F, Kappler C, Schramm E, Riemann D, Weyerer S. Sleep onset insomnia, sleep maintaining insomnia, and insomnia with early morning awakening: temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep. 1994;17:551–554. - PubMed
-
- National Institutes of Health: Drugs and Insomnia: The Use of Medications to Promote Sleep: NIH Consensus Development Conference; National Institutes of Health Consensus Development Conference Summary; 1984. pp. 1–19. - PubMed
-
- National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13–15, 2005; Sleep; 2005. pp. 1049–1057. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous